Clinical Trials
All Clinical Trials - Page 2 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07825857Phase 2Not Yet Recruiting
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Tirzepatide
- NCT07845500Phase 3Not Yet Recruiting
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Tirzepatide
- NCT07809568N/ANot Yet Recruiting
Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes
Tirzepatide
- NCT07772960Phase 1Not Yet Recruiting
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Semaglutide
- NCT07816744N/ANot Yet Recruiting
Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression
Semaglutide
- NCT07755085Phase 4Not Yet Recruiting
GLP-1s in Hip and Knee Arthroplasty
Semaglutide
- NCT07782840Phase 2Not Yet Recruiting
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
Gonadorelin
- NCT07808879N/ARecruiting
Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization
Exenatide
- NCT07739537Phase 4Not Yet Recruiting
PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Orforglipron
- NCT07782359Phase 1Not Yet Recruiting
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
Tirzepatide
- NCT07387796N/ARecruiting
Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
Tirzepatide
- NCT07758231Phase 1Not Yet Recruiting
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Tirzepatide
- NCT07859150Phase 4Not Yet Recruiting
Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)
Semaglutide
- NCT07859163Phase 4Not Yet Recruiting
Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain
Semaglutide
- NCT07859176Phase 4Not Yet Recruiting
Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery
Semaglutide
- NCT07677891Phase 2Not Yet Recruiting
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
Dulaglutide
- NCT07843862Phase 2Not Yet Recruiting
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
Mazdutide
- NCT07855133Phase 1Not Yet Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
Semaglutide
- NCT07801898Phase 2Not Yet Recruiting
Neoadjuvant Endocrine Therapy Combined With Chemotherapy in ER-positive, HER2-negative Stage I-III Breast Cancer
Gonadorelin
- NCT07767552N/ANot Yet Recruiting
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
Mazdutide
- NCT07843498Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
Petrelintide
- NCT07843485Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Petrelintide
- NCT07843472Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
Petrelintide
- NCT07589686Phase 2Not Yet Recruiting
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
Petrelintide
- NCT07845578Phase 1Not Yet Recruiting
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Semaglutide
- NCT07668414Phase 3Recruiting
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Semaglutide
- NCT07846956N/ANot Yet Recruiting
NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study
Tirzepatide
- NCT07734792Phase 2/Phase 3Not Yet Recruiting
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide
- NCT07817251Phase 3Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Semaglutide
- NCT07734870Phase 2Recruiting
Tirzepatide for Treatment of CCCA
Tirzepatide
- NCT07713992N/ANot Yet Recruiting
Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Semaglutide
- NCT07824895Phase 4Not Yet Recruiting
Mazdutide for Weight Management and Gout in Adults With Obesity
Mazdutide
- NCT07803744Phase 1Recruiting
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Tirzepatide
- NCT07777575Phase 4Recruiting
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Tirzepatide
- NCT07793019Phase 1Recruiting
IBI3042 Study in Healthy Participants and Overweight or Obese Participants
Orforglipron
- NCT07822061Phase 3Recruiting
AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight
Amycretin
- NCT06913023Phase 2/Phase 3Not Yet Recruiting
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
Semaglutide
- NCT07768813Phase 1Recruiting
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Survodutide
- NCT07715929Phase 4Not Yet Recruiting
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
Tirzepatide
- NCT07728812N/ANot Yet Recruiting
Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy
Tirzepatide
- NCT07783854Phase 4Not Yet Recruiting
A Randomized Controlled Study of Dose-tapering Regimen of Semaglutide for Weight-Loss Maintenance in Adults With Overweight or Obesity
Semaglutide
- NCT07770152Phase 4Not Yet Recruiting
Semaglutide in Youth With Autism Spectrum Disorder
Semaglutide
- NCT07651319Phase 1/Phase 2Recruiting
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
Semaglutide
- NCT07485062Phase 4Not Yet Recruiting
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
Semaglutide
- NCT07769047Phase 4Not Yet Recruiting
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
Semaglutide
- NCT07718126Phase 4Recruiting
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
Mazdutide
- NCT07797101N/ANot Yet Recruiting
Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis
Mazdutide
- NCT07775846Phase 4Not Yet Recruiting
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Mazdutide
- NCT07657676Phase 4Not Yet Recruiting
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Mazdutide
- NCT07817875Phase 3Not Yet Recruiting
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Tirzepatide